Center of Excellence for Neural Plasticity and Brain Disorders BRAINCITY comprises of 4 research laboratories and is created as the International Research Agenda under the partnership of the European Molecular Biology Laboratory (EMBL).
The key aims of BRAINCITY are to advance scientific understanding of the mechanisms of brain disease and thus identify critical target genes and molecules to find biomarkers for better diagnosis, prediction and monitoring of the diseases, and to develop novel therapeutic approaches targeting abnormal genes, proteins, and neuronal network deficiencies.
EMBL partnership provides active support, offering complementary knowledge in neuroscience, training and management approaches, as well as technology transfer best practices.
